Group 1 - The company Chengdu Yuandong Biopharmaceutical Co., Ltd. is convening its first extraordinary general meeting of shareholders in 2025 on August 1, 2025, at 14:00 [1][2] - The voting method for the meeting will combine on-site voting and online voting through the Shanghai Stock Exchange network voting system [1][2] - The meeting will review proposals that have been approved by the company's fourth board of directors during its sixth meeting [2][3] Group 2 - Shareholders can vote through the Shanghai Stock Exchange network voting system, with specific voting times outlined for both trading and internet platforms [1][3] - The company will provide a reminder service for shareholders to participate in the meeting and vote, utilizing smart SMS notifications [3][5] - The registration for attending the meeting requires specific identification and documentation, with a deadline for submission set for July 29, 2025 [5][6] Group 3 - The meeting will include voting on non-cumulative proposals, including the removal of an independent director and the election of a new independent director [7][8] - Shareholders must complete voting on all proposals before submitting their votes [3][4] - The company will not accept telephone registrations for the meeting, emphasizing the need for physical or electronic submission of required documents [5][6]
苑东生物: 苑东生物:关于召开2025年第一次临时股东大会的通知